Fixed-Combinations and Single-Entity Versions of Previously Approved Antiretrovirals for the Treatment or Prevention of Human Immunodeficiency Virus-One Under the President’s Emergency Plan for Acquired Immunodeficiency Syndrome Relief
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
August 1, 2023
August 2, 2023
a7806ed2-daae-4932-9169-94ac075dfc10
Related Documents
PDUFA Waivers, Reductions, and Refunds for Fixed- Combinations and Single-Entity Versions of Previously Approved Antiretrovirals under PEPFAR
Guidance DocumentAugust 3, 2023Center for Drug Evaluation and Research
Acute Radiation Syndrome: Developing Drugs for Prevention and Treatment
Guidance DocumentApril 19, 2023Center for Drug Evaluation and Research
Dry Eye: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentDecember 16, 2020Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox